Immunoproteasome impairment via β5i/LMP7‐deletion leads to sustained pancreatic injury from experimental pancreatitis-Reference-Cited by-同舟云学术

Immunoproteasome impairment via β5i/LMP7‐deletion leads to sustained pancreatic injury from experimental pancreatitis

Published:2021-06-15 Issue:14 Volume:25 Page:6786-6799
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Freitas Chama Laura L.¹,Ebstein Frédéric²,Wiesrecker Birthe¹,Wagh Preshit R.¹,Hammer Elke³⁴,Weiss Frank U.¹,Junker Heike²,Studencka‐Turski Maja²,Lerch Markus M.¹,Krüger Elke²,Sendler Matthias¹

Affiliation:

1. Department of Medicine A University Medicine Greifswald Greifswald Germany

2. Institute of Medical Biochemistry and Molecular Biology University Medicine Greifswald Greifswald Germany

3. Department of Functional Genomics Interfaculty Institute for Genetics and Functional Genomics University Medicine Greifswald Greifswald Germany

4. German Center for Cardiovascular Research Partner Site Greifswald Greifswald Germany

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16682

Reference62 articles.

1. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats

2. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis

3. English language version of the S3-consensus guidelines on chronic pancreatitis: Definition, aetiology, diagnostic examinations, medical, endoscopic and surgical management of chronic pancreatitis

4. Global incidence and mortality of pancreatic diseases: a systematic review, meta-analysis, and meta-regression of population-based cohort studies

5. The effect of chloroquine administration on two experimental models of acute pancreatitis

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant chemo‐ or chemo‐radiation‐therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass;International Journal of Cancer;2024-02-14

2. Identification of eight novel proteasome variants in five unrelated cases of proteasome-associated autoinflammatory syndromes (PRAAS);Frontiers in Immunology;2023-08-04

3. Neoadjuvant Chemotherapy or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Differentially Shift Immune Activation, ECM Composition, Energy Metabolism, and Ribosomal Proteins of the Residual Tumor Mass;2023-03-09

4. Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling;Frontiers in Immunology;2023-03-02

5. Immunoproteasomes control activation of innate immune signaling and microglial function;Frontiers in Immunology;2022-10-06